<SEC-DOCUMENT>0001628280-17-009315-index.html : 20170914
<SEC-HEADER>0001628280-17-009315.hdr.sgml : 20170914
<ACCEPTANCE-DATETIME>20170914171343
ACCESSION NUMBER:		0001628280-17-009315
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170914
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170914
DATE AS OF CHANGE:		20170914

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mirati Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001576263
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				462693615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35921
		FILM NUMBER:		171086255

	BUSINESS ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-332-3410

	MAIL ADDRESS:	
		STREET 1:		9393 TOWNE CENTRE DRIVE
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8kpressreleasereprelimdat.htm
<TEXT>
Document 1 - file: a8kpressreleasereprelimdat.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>iaslcchicagodata.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: iaslcchicagodata.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>miratilogopurplev3.jpg
<TEXT>
Document 3 - file: miratilogopurplev3.jpg

</DOCUMENT>
</SEC-DOCUMENT>